(BRONX, NY) – Stanley G. Nathenson, M.D., distinguished professor of microbiology and immunology and of cell biology at the Albert Einstein College of Medicine of Yeshiva University, has received the second annual Marshall S. Horwitz, M.D. Faculty Prize for Research Excellence during a special ceremony at the medical school.
The award was established in memory of a beloved long-time member of the Einstein faculty, Marshall S. Horwitz, M.D., who died in 2005. The award was presented to Dr. Nathenson by Allen M. Spiegel, M.D., The Marilyn and Stanley M. Katz Dean at Einstein.
As part of the program Dr. Nathenson delivered the second annual Marshall S. Horwitz, M.D. Prize Lecture, which focused on his current area of research—transplant immunity and costimulation of T cells.
Since joining the Einstein faculty in 1965, Dr. Nathenson has played a key role in making immunological research an area of excellence at the medical school. An internationally prominent cell biologist and immunologist, Dr. Nathenson gained particular recognition for studies that helped reveal the immunological basis for the rejection of transplanted tissues and organs—research that has led to therapies for overcoming the rejection process. As a result, transplantation has now become a routine medical procedure, extending and enhancing the lives of thousands of people every year.
A member of the National Academy of Sciences, Dr. Nathenson’s current research focuses on two costimulatory molecules, B7-1 and B7-2, which have been found to play an important role in activating and regulating T cell immunity—actions that are necessary in preventing tissue or organ rejection during transplantation.
Dr. Nathenson is the author of more than 200 research papers. He currently holds the Samuel H. Golding Chair in Microbiology at Einstein and was named a distinguished professor in 2005.
A resident of Pelham, Dr. Nathenson earned his bachelor’s degree from Reed College in 1955 and his medical degree from Washington University School of Medicine in 1959.